Press Releases Starpharma Holdings Limited

Equities

Market Closed - Australian S.E. Other stock markets 11:40:57 27/06/2024 am IST			5-day change	1st Jan Change
0.087 ^AUD	-2.25%		-3.33%	-48.82%

08/04	Starpharma, Medicxi Co-Found Petalion Therapeutics; Shares Surge 16%	MT
18/03	Starpharma Holdings Limited(ASX:SPL) dropped from S&P/ASX Emerging Companies Index	CI

Starpharma with Proactive at the ASX Small and Mid-Cap Conference	22/23/22	AQ
Starpharma : Quarterly Activities Report & Appendix 4C	29/22/29	PU
Starpharma : Quarterly Cashflow and Activities Report	29/22/29	PU
Starpharma : Application for quotation of securities - SPL	17/22/17	PU
Starpharma : Interim Report and Half-Year Financial Results	21/22/21	PU
Starpharma : Application for quotation of securities - SPL	01/22/01	PU
Starpharma - Quarterly Cashflow and Activities Report	31/22/31	AQ
Starpharma : Quarterly Cashflow and Activities Report	28/22/28	PU
Starpharma receives $7.7M R&D tax incentive refund	21/22/21	AQ
Starpharma - VIRALEZE antiviral nasal spray registered in Saudi Arabia	15/21/15	AQ
Starpharma : Notification regarding unquoted securities - SPL	03/21/03	PU
Starpharma : AGM Chairman address and CEO presentation	30/21/30	PU
Starpharma to present at Bell Potter Healthcare Conference	09/21/09	PU
Starpharma : VIRALEZE™ now launched by LloydsPharmacy in the UK	30/21/30	PU
Starpharma : VIRALEZE to be launched with Lloyds Pharmacy in the UK	25/21/25	AQ
Starpharma : VIRALEZE™ to be launched with LloydsPharmacy in the UK	25/21/25	PU
Starpharma : DEP HER2-lutetium outperforms in human breast cancer model	17/21/17	AQ
Starpharma : DEP® HER2-lutetium outperforms in human breast cancer model	16/21/16	PU
Starpharma : SPL7013 active against other pandemic coronaviruses	04/21/04	AQ
Starpharma : VIRALEZE antiviral nasal spray registered in Europe	23/21/23	AQ

No results for this search